Keros Therapeutics shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $802k | 39k | 20.36 |
| 2025-09-30 | $620k | 39k | 15.82 |
| 2025-06-30 | $185k | 14k | 13.35 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management